Karin Marie Hardiman MD
Associate Professor, Surgery, University of Alabama at Birmingham
Join to View Full Profile
1717 6th Ave SBirmingham, AL 35233
Phone+1 800-822-8816
Dr. Hardiman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Oregon Health & Science University (OHSU Health)Residency, Colon and Rectal Surgery, 2010 - 2011- Oregon Health & Science University (OHSU Health)Residency, Surgery, 2004 - 2010
University of Alabama School of MedicineClass of 2004
Certifications & Licensure
OR State Medical License 2010 - Present
AL State Medical License 2019 - 2025
MI State Medical License 2011 - 2021
American Board of Colon and Rectal Surgery Colon & Rectal Surgery
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- Empowering Futures: The Impact of Surgical Research Pipeline Programs on Undergraduate Career Development.Ashba Allahwasaya, Ramsha Akhund, Polina Zmijewski, Kristi Herritz, Herbert Chen
Journal of Surgical Education. 2025-02-01 - 1 citationsHigh risk populations for unplanned healthcare utilization following ostomy construction.Hannah Ficarino Sheffer, Madi Bruce, Chandler McLeod, Joshua Richman, Karin Hardiman
American Journal of Surgery. 2025-01-01 - Molecular differentiation between complete and incomplete responders to neoadjuvant therapy in rectal cancer.Zechen Chong, Fengyuan Huang, M McLeod, Regina Irwin, Mary Smithson
Research Square. 2024-07-01
Press Mentions
Translational Research in Colorectal CancerApril 1st, 2018
Finding Adds Complexity to Targeted Therapies for Rectal CancerDecember 2nd, 2015
Grant Support
- A novel, transferable sialylation-mediated mechanism of chemoradioresistance in GI cancerUNIVERSITY OF ALABAMA AT BIRMINGHAM2022–2027
- A novel, transferable sialylation-mediated mechanism of chemoradioresistance in GI cancerUNIVERSITY OF ALABAMA AT BIRMINGHAM2022–2027
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
